Mangalam Drugs & Organics
add_icon

Mangalam Drugs & Organics

31.34
-0.63
(-1.97%)
Market Cap
49.61 Cr
PE Ratio
-1.60
Volume
7,074.00
Day High - Low
31.34 - 31.34
52W High-Low
95.00 - 22.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
49.61 Cr
EPS
4.25
PE Ratio
-1.60
PB Ratio
0.41
Book Value
76.13
EBITDA
36.30
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
4.51
Debt to Equity
0.73
Forecast For
Actual

Company News

View All News
Caret
positive
Shree Kishoriju Trading releases 1,500 pledged shares of Mangalam Drugs & Organics, reducing encumbered holdings from 3.21% to 3.20% of total share capital.
neutral
Mangalam Drugs & Organics Limited submitted its quarterly compliance certificate under SEBI Depositories Regulations for the quarter ended March 31, 2026, confirming proper handling of dematerialisation processes.
neutral
Mangalam Drugs & Organics board accepts resignation of Ms. Anuradha Pandey as Company Secretary effective March 29, 2026, and appoints Ms. Shweta Patel as new CS from April 1, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,654.90
#1 3,97,065.94
37.62
#1 54,729.00
9.71
#1 10,980
16.07
34.03
6,116.50
1,62,373.86
63.80
9,712.00
18.67
2,191
-1.02
53.67
4,155.20
1,40,630.85
60.97
11,539.40
6.99
1,911
26.24
47.83
2,333.80
1,06,664.75
22.48
22,909.50
13.74
3,306
#1 37.44
57.51
1,232.20
1,02,844.71
18.32
33,741.20
16.73
5,725
-15.28
45.58
1,229.50
99,316.63
21.81
28,409.50
7.12
5,291
-57.18
40.75
915.40
92,110.66
#1 18.06
23,511.00
18.55
4,615
-0.32
57.32
2,079.00
85,822.17
47.03
12,744.20
#1 20.90
2,007
7.65
51.63
1,349.40
78,373.37
22.33
32,345.60
9.43
3,484
7.59
65.82
5,440.00
65,043.36
26.50
13,458.30
3.70
2,216
1.90
53.68

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-13.56 %
Net Income Growth
-173.63 %
Cash Flow Change
989.26 %
ROE
-167.51 %
ROCE
571.43 %
EBITDA Margin (Avg.)
140.00 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
97
102
77
80
89
73
57
49
59
Expenses
90
91
68
71
80
63
62
52
60
EBITDA
7
12
8
9
9
10
-5
-3
-1
Operating Profit %
7 %
11 %
11 %
11 %
10 %
14 %
-8 %
-6 %
-3 %
Depreciation
4
4
4
4
4
5
5
5
5
Interest
3
4
4
4
4
4
4
5
4
Profit Before Tax
0
4
1
1
1
2
-13
-13
-10
Tax
-1
0
-2
-2
0
2
1
-5
0
Net Profit
1
4
3
3
1
0
-14
-7
-10
EPS in ₹
0.31
2.23
1.70
1.70
0.81
0.04
-8.72
-4.64
-6.21

Balance Sheet

Balance Sheet
2024
2025
Total Assets
334
366
Fixed Assets
148
163
Current Assets
176
199
Capital Work in Progress
8
3
Investments
0
0
Other Assets
178
201
Total Equity & Liabilities
334
366
Current Liabilities
164
192
Non Current Liabilities
34
26
Total Equity
136
149
Reserve & Surplus
120
133
Share Capital
16
16

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
-3
1
Investing Activities
-12
-20
Operating Activities
4
43
Financing Activities
5
-22

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
50.53 %
50.53 %
50.53 %
50.53 %
50.53 %
50.42 %
50.42 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.30 %
50.30 %
50.30 %
50.30 %
50.30 %
35.64 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.10 %
0.26 %
0.21 %
0.11 %
0.11 %
0.47 %
0.53 %
0.11 %
0.13 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
44.27 %
42.68 %
44.53 %
44.39 %
43.85 %
44.18 %
44.12 %
44.27 %
44.22 %
44.64 %
44.54 %
44.43 %
44.22 %
44.70 %
44.91 %
44.78 %
44.55 %
44.53 %
45.00 %
57.52 %
Others
5.19 %
6.78 %
4.93 %
5.07 %
5.61 %
5.40 %
5.46 %
5.41 %
5.46 %
5.05 %
5.14 %
5.15 %
5.20 %
4.77 %
4.67 %
4.80 %
4.68 %
4.63 %
4.59 %
6.70 %
No of Share Holders
0
20,520
21,827
21,071
20,668
20,084
18,988
18,483
17,943
17,890
17,978
18,610
19,173
19,312
19,508
19,679
19,697
19,728
19,881
21,227

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 130.33 124.37
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 110.36 105.03
13 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2025 109.00 110.75
17 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 May 2025 78.66 82.30
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 87.56 84.03
12 Aug 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Aug 2025 85.56 77.13
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 78.43 72.22
20 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Nov 2025 66.04 54.61
15 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 Jan 2026 33.42 44.77

Announcements

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.2 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20186 days ago
Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2026
Board Meeting Outcome for Outcome Of Board Meeting For Resignation Tendered By CS Anuradha Pandey Accepted By The Board Approval For The Appointment Of New Company Secretary Nominated By NRC Ms. Shweta Patel.Mar 26, 2026
Board Meeting Intimation for Board Meeting Intimation To Be Held On 26Th March 2026Mar 24, 2026
Closure of Trading WindowMar 24, 2026
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 18, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 18, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 18, 2026
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 17, 2026
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 17, 2026
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent DisclosureMar 17, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th February 2026Feb 06, 2026
Board Meeting Intimation for To Consider And Approve Appointment Of Chief Financial Officer Of The Company And Any Other Businesses.Feb 04, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 03, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 17, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorJan 17, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 16, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 15, 2026
Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025Jan 15, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 15Th January 2026 Inter Alia To Approve Un-Audited Financial Results For The Quarter Ended 31St December 2025Jan 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Board Meeting Intimation for Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025.Jan 07, 2026
Revert To The Query Raised By BSE Surveillance Department Dated 5Th January 2026 Regarding Clarification In Price Movement.Jan 07, 2026
Clarification sought from Mangalam Drugs & Organics LtdJan 05, 2026
Closure of Trading WindowJan 01, 2026
Explanation To The Intimation Filed On 29Th March 2025 Regarding Resignation Of Chief Financial Officer Of The Company.Dec 24, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 21, 2025
Declaration Of Un-Audited Financial Results For The Quarter Ended 30Th September 2025Nov 20, 2025
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 20Th November 2025 At 12:00 P.M. To Approve Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30Th September 2025Nov 20, 2025
Defaults under Para A sub-paragraph 6 of Schedule III-Initial DisclosureNov 18, 2025
Results-Delay in Financial ResultsNov 13, 2025
Board Meeting Intimation for Postponement Of Board Meeting To Be Held On 20Th November 2025Nov 13, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Nov 11, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 13Th November 2025 To Consider And Approve Un-Audited Financial Results(Standalone And Consolidated) For The Quarter Ended 30Th September 2025.Nov 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 16, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementOct 15, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementOct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Closure of Trading WindowSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 19, 2025
Announcement Under Regulation 30 Of SEBI(LODR)Regulations 2015 For Submission Of Corrigendum For 52Nd Annual Report Of 2024-25.Sep 19, 2025
Reg. 34 (1) Annual Report.Sep 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Intimation Of 52Nd Annual General Meeting Of The Company To Be Held On 29Th September 2025 At 3:00 P.M. Through Video Conferencing/ Other Audio Visual Means.Sep 07, 2025

Technical Indicators

RSI(14)
Neutral
52.47
ATR(14)
Less Volatile
1.80
STOCH(9,6)
Overbought
80.75
STOCH RSI(14)
Overbought
95.50
MACD(12,26)
Bullish
0.42
ADX(14)
Weak Trend
23.45
UO(9)
Bearish
65.81
ROC(12)
Uptrend And Accelerating
3.77
WillR(14)
Neutral
-26.15